References
- Byerly M, Goodman W, Acholonu W, Bugno R, Rush AJ. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res 2005; 76: 309–316
- Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive–compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?. J Psychiatry Neurosci 2005; 30: 187–193
- Poyurovsky M, Weizman A, Weizman R. Obsessive–compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 2004; 18: 989–1010
- Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive–compulsive disorder. Mol Psychiatry 2006; 11: 622–632
- Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 333–346
- Reznik I, Yavin I, Stryjer R, et al. Clozapine in the treatment of obsessive–compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry 2004; 37: 52–56
- Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive–compulsive disorder. J Clin Psychiatry 1999; 60: 101–106
- Zink M, Dressing H. Augmentation of clozapine with atypical antipsychotic substances. Current Psychiatry Rev 2005; 1: 165–172
- Rocha FL, Hara C. Benefits of combining aripiprazole to clozapine: three case reports. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1167–1169
- Connor KM, Payne VM, Gadde KM, et al. The use of aripiprazole in obsessive–compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 2005; 66: 49–51